Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten Langer

Showing results (11-20 of 160) with videos related to

Pageof 16
Sort By:
Innere Medizin (Heidelberg, Germany)|May 19, 2025
[Organizing survivorship: transition and long-term care for childhood cancer survivors]Madelaine Sleimann, Thorsten Langer, Judith Gebauer
Neuropediatrics|February 23, 2022
Parents' Perspectives on Diagnosis and Decision-Making regarding Ventilator Support in Children with SMA Type 1Astrid Pechmann, Thorsten Langer, Janbernd Kirschner
Frontiers in Pediatrics|August 20, 2021
Evaluation of a Case Management to Support Families With Children Diagnosed With Spinal Muscular Atrophy-Protocol of a Controlled Mixed-Methods StudyJana Willems, Erik Farin-Glattacker, Thorsten Langer
Developmental Medicine and Child Neurology|December 31, 2024
Measuring what really matters: Why developing patient-reported outcome measures in Duchenne muscular dystrophy should involve patients and caregiversSebastian Friedrich, Gudrun Reeskau, Joachim Sproß, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|December 7, 2017
Single-center experience with intrathecal administration of Nusinersen in children with spinal muscular atrophy type 1Astrid Pechmann, Thorsten Langer, Sabine Wider, et al.
Orphanet Journal of Rare Diseases|July 31, 2020
Experiences of caregivers of children with spinal muscular atrophy participating in the expanded access program for nusinersen: a longitudinal qualitative studyPetra Kiefer, Janbernd Kirschner, Astrid Pechmann, et al.
Frontiers in Public Health|October 7, 2024
Editorial: International Day of Persons with Disabilities - children's disabilitiesOlaf Kraus de Camargo, Nihad A Almasri, Thorsten Langer
Orphanet Journal of Rare Diseases|June 2, 2023
Barriers and facilitating factors of care coordination for children with spinal muscular atrophy type I and II from the caregivers' perspective: an interview studyJana Willems, Isabella Bablok, Erik Farin-Glattacker, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 23, 2020
[Incidence of exercise intolerance, organ system impairment, and mortality in adult childhood cancer survivors]Diana Steinmann, Thorsten Langer, Tienush Rassaf, et al.
Endocrine Reviews|November 27, 2018
Long-Term Endocrine and Metabolic Consequences of Cancer Treatment: A Systematic ReviewJudith Gebauer, Claire Higham, Thorsten Langer, et al.
Pageof 16

Showing results (11-20 of 160) with videos related to

Sort By:
Pageof 16
Innere Medizin (Heidelberg, Germany)|May 19, 2025
[Organizing survivorship: transition and long-term care for childhood cancer survivors]Madelaine Sleimann, Thorsten Langer, Judith Gebauer
Neuropediatrics|February 23, 2022
Parents' Perspectives on Diagnosis and Decision-Making regarding Ventilator Support in Children with SMA Type 1Astrid Pechmann, Thorsten Langer, Janbernd Kirschner
Frontiers in Pediatrics|August 20, 2021
Evaluation of a Case Management to Support Families With Children Diagnosed With Spinal Muscular Atrophy-Protocol of a Controlled Mixed-Methods StudyJana Willems, Erik Farin-Glattacker, Thorsten Langer
Developmental Medicine and Child Neurology|December 31, 2024
Measuring what really matters: Why developing patient-reported outcome measures in Duchenne muscular dystrophy should involve patients and caregiversSebastian Friedrich, Gudrun Reeskau, Joachim Sproß, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|December 7, 2017
Single-center experience with intrathecal administration of Nusinersen in children with spinal muscular atrophy type 1Astrid Pechmann, Thorsten Langer, Sabine Wider, et al.
Orphanet Journal of Rare Diseases|July 31, 2020
Experiences of caregivers of children with spinal muscular atrophy participating in the expanded access program for nusinersen: a longitudinal qualitative studyPetra Kiefer, Janbernd Kirschner, Astrid Pechmann, et al.
Frontiers in Public Health|October 7, 2024
Editorial: International Day of Persons with Disabilities - children's disabilitiesOlaf Kraus de Camargo, Nihad A Almasri, Thorsten Langer
Orphanet Journal of Rare Diseases|June 2, 2023
Barriers and facilitating factors of care coordination for children with spinal muscular atrophy type I and II from the caregivers' perspective: an interview studyJana Willems, Isabella Bablok, Erik Farin-Glattacker, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 23, 2020
[Incidence of exercise intolerance, organ system impairment, and mortality in adult childhood cancer survivors]Diana Steinmann, Thorsten Langer, Tienush Rassaf, et al.
Endocrine Reviews|November 27, 2018
Long-Term Endocrine and Metabolic Consequences of Cancer Treatment: A Systematic ReviewJudith Gebauer, Claire Higham, Thorsten Langer, et al.
Pageof 16